Brain+ begins early activity and brand building in the US
Copenhagen, Denmark, October 19, 2022 – Brain+ A/S (Nasdaq First North: BRAINP) · The United States (US) is a key future market for Brain+, and early brand building and exploration is now ongoing · Brain+ has been selected and featured as a 2022 TMC-Denmark BioBridge Partner in the new Texas Medical Center (TMC) new 2022 Biobridge e-book. TMC is the largest medical city in the world · 7+ million people ages 65 or older had in the US dementia in 2020 · US reimbursement/price levels for Digital Therapeutics (Dtx) at $1000 and beyond · The US market potential for DTx for